What makes Bio health a lucrative deal...
That CGB are moving straight into manufacturing Canntab Tablets and Pharmocann products…that what makes it so huge…
CGB have a huge opportunity with Bio Health manufacturing and exporting into Asian markets..
Bonify shot itself in the foot with having its license suspended otherwise Bonify would have had huge potential also. While Bonify are in damage control, the Bio Health deal is the best path, if not better deal, moving forward with manufacturing, exporting tablets, skin care and oil capsules products..
6-8 to relist with a YES VOTE attached and on target to relist end of March with sales of Hemp wholefoods products, a huge hemp harvest crop with a huge potential Asian market with Canntab, Pharmocann and Vitahemp products.
That’s lot of potential customers and more lucrative deals ahead with potential investors looking into CGB…and speculating new players looking into an investing in CGB…
And speculating further Announcements from here to then, with Medcan, BHC, relationships.. potential MM products with (speculation newer concepts/players with dried flowers potential)
CGB Warp Speed ahead…
Best wishes to all shareholders
Have a good weekend to all
taiji
Bio Health
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
